Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

experience *expression 63

Keyword

Abstract

SKeyword

Abstr

es in victims of rape the at St. Gabriel's hospital in Mal
/Mobilising resources, and support networks to assist
dicines logistic - Santos /STD: Medicines logistic - San
viours: Harm reduction of Villa Maraini's Street Unit/O
gning an individualized /Mini-residency/mini-precepto
Central-African country, Democratic Republic of Cong
frica: The C6te d'lvoire /Determinants of HIV transmis
eatment-naive or AZT - Experienced HIV-1 infected adult patients
nalogs in nucleoside experienced subjects/ACTG 364: Virologi
s sequential therapy in HIV patients: The MASTER s
promised, antiretroviral children with perinatal HIV-1
ine alone in zidovudine, HIV-infected patients/Indin
and seek" games in the of people living with HIV/AID
atment with cidofovir in patients: Results of the Germ
navir) therapy in HIV-1 patients (ZDV + ddC/ddl) wit
ucleoside analogue HIV-1 infected patients: Char
n protease inhibitor (PI) patients/Combination therap
on therapy in treatment HIV/AIDS patients, following
er system in treatment HIV-infected patients. Immu
le combination in HIV-1 patients/The effect of triple c
naive and antiretroviral HIV+ patients/Zidovudine (Z
escue therapy in highly patients/Hour drug therapy i
e in treatment naive and patients/Combination therap
ranscriptase inhibitors/ Experiences in protease inhibitor use in p

60803
60847
60855
60867
60931
60962
60986
22382
125*/12203
12232
12254
12335
12459
22256
22344
22386
22391
32295
32297
41189
509*/42260
60480
60701
12340
13489
22197
24241
32334
33133
42297
43249
14224
22152
22457
45*/24247
24317
32395
32428
33135
248*/33192
33375
33470
108*/34309
43211
60308

pressive factors by HIV,uninfected (EU) individuals/Enh
unological profile in HIV seronegative subjects/Study of i
R5) genotype in highly but persistently seronegative fem
ylaxis of occupationally health care workers at two large
o health care workers to HIV in an university hospital in
gnosis of HIV vertically infants in Belo Horizonte, Brazil/
V infection in perinatally children/Serum y-globulin level
V infection in perinatally children/Serum y-globulin level
replication/CD8+ cells to B7.2 but not B7.1 during activa
thers to HIV/Knowingly exposing others to HIV/Knowingly
vis infection and risk of exposition among West African people w
se the female condom: Exposure to semen during use/A prospec
medicalpersoneltoHIV/ of medical personel to HIV/
trarectal or intravaginal exposure of macaques/Genetic character
e on route of challenge /Recombinant vaccine-induced
es/Health care workers (HCWE): Analysis of 113 cases
kers after occupational /Risk of HIV infection in health c
als presenting for post- prophylaxis (PEP) following hig
al assault/Post-sexual prophylaxis (PSEP) with HAAR
s after an occupational to HIV: A no show/Follow-up of
ation antiretroviral post prophylaxis/Zidovudine and co
sure/Feasibility of post- prevention research among wo
body fluid occupational in Rio de Janeiro City/Implemen
may benefit?/Post HIV prophylaxis: Who may benefit?/
n-based HIV accidental program/Pharmaceutical costs
abandon condoms after to a safer-sex hierarchy?/Do wo
g about AIDS? - Media to AIDS and discussion with frie
tner notification for HIV /Now is the time to re-examine p
nt of the HIV accidental prophylaxis program in British C
risk comparison for HIV /New and long-term injection dr

act31140
31146
31147
33178
33195
42117
42399
42407
60406
60562
22143
33132
60852
11221
548*/21200
23335
23336
33173
250*/33174
33177
33182
33186
33187
33188
33191
33276
33446
43556
60162
60271

ttitudes towards HIV.
e and incidence of HIV:
psychiatric mobil team:
ART) in the "real world":
e condom for anal sex/
g in antiretroviral drugs/
workers in Pune, India/
I health: Cross-cultural experiences
TB) - Urban and rural
h HIV infection/Nurse's
uthanatic: Subjective
nd dual diagnosis/The
erapy/The health care
isclosure in health care
rs' concerns about and
EP)/French physicians
The impact of personal
n the developing world:
st HIV/AIDS: Uganda's
tos, Brazil/Results and
s and adherence/Poor

of the UNDP/HIV and Develo
in an urban factory cohort in
in the south of France (Mars
in an inner-city community h
of 100 men who have sex wit
addressing the issue of acce
in peer education approach f
in learning about sex and its i
of different perspectives, We
caring for children with HIV in
from care providers/Morphin
of managing clients with AID
of HIV-positive transgendere
of HIV-positive bisexual men
with the female condom/Wo
and attitudes about non-occu
with HIV/AIDS on behaviours
from Uganda/Building an HI
and the way forward/The rol
of the World AIDS Day camp
of health care leads to avoida

HIV-positive individuals experiencing symptoms/Randomized co 22458
WA/The importance of solidarity: Specific support f 60320
China/Pilot program in experiential HIV/AIDS education for nurse 13477
of male sex workers: An experiment in planned action/HIV-preven 29*/43367
mangabey to Macaque/ Experimental transmission of SIVrcm isol 11232
pe for SAIDS treatment/ research on traditional Chin 60048
ng prostitutes in Dakar/ activity of reconversion amo 60265
ated gene expression in experimental AIDS-related simian lympho 11216
ntion education through theater/Mobilizing and invol 13423
orkers in France - An training methodology/Teac 24333
adults/Evaluation of an Amplicor DNA PCR assay f 41155
children in Calcutta/An attempt to create awarenes 43313
s and constraints/The experimentation of the participative appro 43188
S Public Health Service Expert Panel on clinical practices: A public 42292
ypic driven rule-based expert artificial intelligence computer syst 32297
ary forces/HIV infection diagnostics problems in the Russia 60964
ween viewing sexually explicit and violent television, pregnancy a 34226
patients/Acquisition of and implicit long-term-memory an 60450
hool girls against sexual exploitation: Development of a guardian p 13533
WHA/Advocacy against of PLWHA/Advocacy against 34287
or commercial sexual children for the STD/HIV prev 43368
9-12 with HIV infection/ Exploration of knowledge of diagnosis an 14269
ransmission of HIV/An exploration of the determinants of sexual 60061
e, what evidence?" An of the factors influencing the d 60441
Brazil/Female condom: Exploratory study in Sao Paulo-Brazil/Fe 23460
eople living with HIV to explore their options for the future in the lig 34315
onal advocacy coalition explores its future/Looking ahead: A natio 34378
attitudes and lifestyles/ Exploring ethnicity and sexual health: Cro 14224
se to HIV/AIDS in India: the gap between positive peopl 34155
binant strain causing an explosive IDU epidemic in Kaliningrad/HI 13190
ors in why people today expose themselves to the risk of being infe 60849
lizing activity and IgA in exposed seronegative (ESN) partners of 21124
infections in perinatally infants/Viral and host genetic ch 23312
hocytes (CTLs) in Thai uninfected (EU) female sex work 599*/31120
ell proliferation in HIV-2 non-infected individuals in Guine 605*/31133

luation of occupational exposures to HIV, HBV and HCV notified i 13471
d States/Occupational resulting in HIV infection in hea 23329
ntability of occupational resulting in human immunodefi 23330
Profile of occupational to blood and body fluids among 23332
impact of occupational to blood and body fluids on hea 24307
(PEP) for occupational to HIV/Tolerability of antiretrov 246*/33171
ccupational and sexual to HIV: experience in a London 247*/33176
s team for occupational to blood-borne pathogens/Effi 33181
ffected by HIV/AIDS/ Express yourself... the art as a therapy wo 42397
g-V3 chimeric particles expressed by a recombinant vaccinia viru 21204
ell lines adapted strains using a Semliki forest virus vec 21207
haracterization of T cell chimeric receptors with antibod 41233
y antisense sequences in CD4+ cells/Broad spectrum 60375
recombinant protein expressing the native V1/V2 domain of gp 550*/21194
nia virus recombinants human cytomegalovirus UL97 31199
CD4-LTR-/3-Gal stably CCR5 suitable for infectivity a 41163
capacity in vitro/HIV-1 the 3TC-associated M184V m 41214
primary acute infection/ Expression of molecules responsible for I 21161
and during treatment/ of CD28 and CD38 by CD8+ T 116*/31170
and HIV-1(-) patients/ of adhesion molecules in recu 32250
e like particles (CLP) by expression of the HIV-1 gag gene in a Bac 11136
cular analysis of mRNA of HIV-infected T cell using hig 380*/11139
echanism regulates the of the human endogenous retr 11208
apoptosis-related gene in experimental AIDS-related 11216
CCR1, IFNy, RANTES in lymphoid tissues/Simian im 11222
mphocytes and Fas Ag in early phase of SIVmac infec 11227
HLA-DR and CD45RO, Interleukin-2 synthesis and a 12180
of chemokine receptor in the female genital tract: Pro 335*/21109
ive controls/Increased of chemokine co-receptors on 21119
kines and their receptor in adult Simian astrocytes cult 21144
erations in cellular gene: High density cDNA analysis o 21152
effects of IL-4 on HIV-1 suggest a role in viral phenoty 218*/21174
Prevalence and clinical of herpes simplex virus infecti 22191
s preceded by the over- of molecules associated with 22290
neoplasia/Local HIV-1 in the female genital tract folio 22310
d chemokine receptors during combined anti HIV-1 IL 22416
on chemokine receptor in CD4+ tetanus toxoid specifi 31141
n in HIV+ children/The of CD38 and DR are markers 213*/31166
tients/Increased CD69 in non-stimulated CD8+ T-cell 31171
ponses/T lymphocytes of CD28 in HIV-1 infected chil 31173
tions of CD45 isoforms in paediatric HIV-1 infection pr 31176
etroviral therapy on the of Fas antigen in patients with 31178
HIV infection affects the of fructose-6-phosphate, 2-kin 32175
rapy/Alterations in HIV in AIDS patients with psoriasis 32265
and activation markers before and after anti-retroviral 41193
nd modulates CXCR-4 in lymphoid cells/CD38 stimul 41234
IL-7) gene transfer and in HIV gpl60-specificT cells fr 41244
AC infection on cytokine in HIV-infected persons/ACT 60279
MSH peptides on HIV-1 in monocytic cells/Inhibitory in 60685
/T cell HLA-DR surface as a surrogate marker for HIV 60864